Focal Segmental Glomerulosclerosis Drug Market to Record a CAGR of 9.5%, North America to be Largest Contributor to Market Growth | Market.us
Pune, Maharashtra, India, October 7 2022 (Wiredrelease) Prudour Pvt. Ltd --:Focal Segmental Glomerulosclerosis Drug Market to grow at a CAGR of 9.5% during the forecast period of 2018 to the 2025. Focal segmental glomerulosclerosis (FSGS) is a type of kidney disease that results in the scarring of kidney filters. The main function of kidney filters is to remove waste and excess water from the blood. FSGS can lead to kidney failure and other serious health problems. There are no specific treatments for FSGS, but there are treatments that can help slow the progression of the disease and improve the quality…
- Date: October 7, 2022
- Author: Quintero
- Category: PharmiWeb